.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Moxie is stocked at 96 licensed dispensaries across Ohio, Pennsylvania, and 3 other states, 48 of them in Ohio, with the deepest coverage in Columbus, Cincinnati, Akron, Ashtabula, and Athens. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Moxie’s category mix concentrated in Flower at 40.50% share and Vapor Pens at 33.52% share, while Edible expanded to 24.95% share; Flower declined year over year by 81.71% and month over month by 9.65%, whereas Vapor Pens fell 46.38% YoY but grew 8.84% MoM. Edible advanced 46.70% YoY and 5.71% MoM, while Concentrates collapsed 98.36% YoY and 61.71% MoM and Pre-Roll contracted 61.65% YoY and 73.50% MoM; this rebalancing implies Moxie is reallocating demand from historically core inhalables toward lower-priced, faster-recovering formats. With average price down 29.58% YoY and overall brand sales down 70.05% YoY, the mix shift alongside a Flower ranking of 52 in Ohio indicates a defensive tilt toward accessible segments while ceding premium Flower volume.
The combination of a 8.84% MoM uptick in Vapor Pens and a 5.71% MoM rise in Edible, against a 9.65% MoM decline in Flower and over 60% MoM pullbacks in both Concentrates and Pre-Roll, suggests Moxie’s short-term positioning hinges on replenishing velocity in scalable, price-sensitive categories. Given Edible’s 46.70% YoY growth and Vapor Pens’ less severe 46.38% YoY contraction compared to Flower’s 81.71% YoY decline, August 2026 points to a portfolio strategy that trades depth in premium inhalables for breadth across approachable formats, which can stabilize unit flow but risks further erosion of differentiation where Flower still anchors category identity and rank.
Competitive Landscape
Moxie sits at rank #52 in OH Flower in August 2026, down 32 positions year over year from #20, and 3 spots below its May 2026 position of #49, indicating deterioration from its July 2025 peak at #15 despite stability in recent months; meanwhile, Klutch Cannabis holds #1 after a 19-rank YoY climb with a 362.3% sales increase, and RYTHM is #2 after improving 8 ranks with 27.3% YoY sales growth, signaling that Moxie’s downward rank trajectory aligns with category leaders widening separation rather than short-term volatility.
Notable Products
GG4 (2.83g) posted the steepest decline at -43.0% month over month and slid to rank 4, while Strawberry Banana Gummies 10-Pack (100mg) fell -18.4% to rank 3. Blueberry Blackberry Gummies 10-Pack (100mg) rose 36.6% to rank 1 and Orange Raspberry Gummies 10-Pack (100mg) gained 10.3% at rank 2. With four of the top ten in Edible SKUs concentrated in the top seven ranks and Flower split between rank 4 and rank 9, the mix implies a pivot toward edibles-led velocity with Flower under pressure on repeat purchase and price realization.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
